Bandar Alosaimi

892 total citations
45 papers, 524 citations indexed

About

Bandar Alosaimi is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Bandar Alosaimi has authored 45 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 13 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Bandar Alosaimi's work include SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (12 papers) and Respiratory viral infections research (9 papers). Bandar Alosaimi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (12 papers) and Respiratory viral infections research (9 papers). Bandar Alosaimi collaborates with scholars based in Saudi Arabia, Egypt and United States. Bandar Alosaimi's co-authors include Maaweya E. Hamed, Asif Naeem, Mushira A. Enani, Wael Alturaiki, Ayman Mubarak, Abdullah M. Assiri, Ahmed Alrashed, Faris Q Alenzi, Huda M. Alshanbari and Sami G. Almalki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and International Journal of Environmental Research and Public Health.

In The Last Decade

Bandar Alosaimi

40 papers receiving 519 citations

Peers

Bandar Alosaimi

EPIDE

NEURO

IMMUN

Zeinab Mohseni Afshar Iran

Jenny Herbert United Kingdom

Jingna Xun China

Nour Chams United States

Maaweya E. Hamed Saudi Arabia

Ko‐Yung Sit Hong Kong

Yanhong Sun China

Waleed H. Mahallawi Saudi Arabia

Timmy Wing‐Kuk Au China

Kenji Nishiura United States

Zeinab Mohseni Afshar Iran

Bandar Alosaimi

212 ×0.7

106 ×0.7

EPIDE

92 ×1.1

NEURO

67 ×0.8

48 ×0.6

IMMUN

Citations per year, relative to Bandar Alosaimi Bandar Alosaimi (= 1×) peers Zeinab Mohseni Afshar

Countries citing papers authored by Bandar Alosaimi

Since Specialization

Citations

This map shows the geographic impact of Bandar Alosaimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bandar Alosaimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bandar Alosaimi more than expected).

Fields of papers citing papers by Bandar Alosaimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bandar Alosaimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bandar Alosaimi. The network helps show where Bandar Alosaimi may publish in the future.

Co-authorship network of co-authors of Bandar Alosaimi

This figure shows the co-authorship network connecting the top 25 collaborators of Bandar Alosaimi. A scholar is included among the top collaborators of Bandar Alosaimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bandar Alosaimi. Bandar Alosaimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marraiki, Najat, et al.. (2025). Profiling the Tumor Immune Microenvironment of HPV-Associated Base of Tongue Squamous Cell Carcinoma. OncoTargets and Therapy. Volume 18. 263–281. 1 indexed citations

Qadri, Ishtiaq, et al.. (2025). Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development. Frontiers in Immunology. 16. 1538301–1538301.

Alamri, Saad, et al.. (2025). Exploring the interplay between EBV and autophagy-related gene expression patterns in nasopharyngeal carcinoma. Frontiers in Oncology. 15. 1588921–1588921.

Alosaimi, Bandar, et al.. (2025). A 10 Year Long‐Lived Cellular and Humoral MERS‐CoV Immunity Cross‐Recognizing the Wild‐Type and Variants of SARS‐CoV‐2: A Potential One‐Way MERS‐CoV Cross‐Protection Toward a Pan‐Coronavirus Vaccine. Journal of Medical Virology. 97(1). e70071–e70071.

Alosaimi, Bandar, et al.. (2024). Predictors of Human Papillomavirus (HPV) Vaccine Acceptability Among Physicians, Their Knowledge on Cervical Cancer, and Factors Influencing Their Decision to Recommend It. Journal of Multidisciplinary Healthcare. Volume 17. 5177–5188. 4 indexed citations

Eifan, Saleh, et al.. (2024). Evolutionary analysis of LMP-1 genetic diversity in EBV-associated nasopharyngeal carcinoma: Bioinformatic insights into oncogenic potential. Infection Genetics and Evolution. 120. 105586–105586. 2 indexed citations

Marraiki, Najat, et al.. (2023). Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma. Cancers. 15(23). 5548–5548. 2 indexed citations

El‐Arabey, Amr Ahmed, et al.. (2023). A bioinformatic analysis of the role of TP53 status on the infiltration of CD8+ T cells into the tumor microenvironment. Brazilian Journal of Medical and Biological Research. 56. e12970–e12970. 2 indexed citations

Aloufi, Abeer S., et al.. (2023). In vivo Evaluation of the Antiviral Effects of Arabian Coffee (Coffea arabica) and Green Tea (Camellia sinensis) Extracts on Influenza A Virus. SHILAP Revista de lepidopterología. 13(3). 154–161. 1 indexed citations

10.

Yasir, Muhammad, Anees Sindi, Mai M. El-Daly, et al.. (2023). Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia. Journal of Infection and Public Health. 16(5). 680–688. 8 indexed citations

11.

Enani, Mushira A., et al.. (2023). Moderately Low Effectiveness of the Influenza Quadrivalent Vaccine: Potential Mismatch between Circulating Strains and Vaccine Strains. Vaccines. 11(6). 1050–1050. 7 indexed citations

12.

Alosaimi, Bandar, et al.. (2023). The correlation between soluble human leukocyte antigen (sHLA‐G) levels and +3010 polymorphism. International Journal of Immunogenetics. 51(1). 39–46. 1 indexed citations

13.

Alosaimi, Bandar, et al.. (2022). Cardiovascular complications and outcomes among athletes with COVID-19 disease: a systematic review. BMC Sports Science Medicine and Rehabilitation. 14(1). 74–74. 11 indexed citations

14.

Alosaimi, Bandar, et al.. (2022). Recall of Prior Knowledge in Medical Microbiology Among Medical Interns: A Multicenter Cross-Sectional Assessment in Saudi Arabia. Advances in Medical Education and Practice. Volume 13. 733–739. 3 indexed citations

15.

Alosaimi, Bandar, Ayman Mubarak, Maaweya E. Hamed, et al.. (2021). Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality. Frontiers in Immunology. 12. 668725–668725. 55 indexed citations

16.

Alosaimi, Bandar, et al.. (2021). Influenza co-infection associated with severity and mortality in COVID-19 patients. Virology Journal. 18(1). 127–127. 101 indexed citations

17.

Alrashed, Ahmed, Tahir Mehmood Khan, Noara Alhusseini, et al.. (2021). Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. Journal of Infection and Public Health. 14(6). 726–733. 9 indexed citations

18.

Alosaimi, Bandar, et al.. (2021). Guillain-BarrE Syndrome Following COVID-19: A Case Report. Journal of Research in Medical and Dental Science. 9(3). 7–10. 3 indexed citations

19.

Alosaimi, Bandar, et al.. (2020). MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract. Journal of Infection and Public Health. 13(2). 371–372. 1 indexed citations

20.

Alosaimi, Bandar, et al.. (2019). MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract. Cytokine. 126. 154895–154895. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact